396 related articles for article (PubMed ID: 21947388)
1. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
Bosso JA; Nappi J; Rudisill C; Wellein M; Bookstaver PB; Swindler J; Mauldin PD
Antimicrob Agents Chemother; 2011 Dec; 55(12):5475-9. PubMed ID: 21947388
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME
Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an AUC
Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
Liu P; Capitano B; Stein A; El-Solh AA
BMC Nephrol; 2017 May; 18(1):168. PubMed ID: 28532398
[TBL] [Abstract][Full Text] [Related]
6. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
[TBL] [Abstract][Full Text] [Related]
7. The Whole Price of Vancomycin: Toxicities, Troughs, and Time.
Jeffres MN
Drugs; 2017 Jul; 77(11):1143-1154. PubMed ID: 28573434
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors for vancomycin-induced nephrotoxicity.
Park SJ; Lim NR; Park HJ; Yang JW; Kim MJ; Kim K; In YW; Lee YM
Int J Clin Pharm; 2018 Oct; 40(5):1328-1334. PubMed ID: 29744794
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
[TBL] [Abstract][Full Text] [Related]
10. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
11. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.
Hall RG; Hazlewood KA; Brouse SD; Giuliano CA; Haase KK; Frei CR; Forcade NA; Bell T; Bedimo RJ; Alvarez CA
BMC Pharmacol Toxicol; 2013 Feb; 14():12. PubMed ID: 23402420
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
[TBL] [Abstract][Full Text] [Related]
13. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
14. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
[TBL] [Abstract][Full Text] [Related]
15. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome.
McNeil JC; Kok EY; Forbes AR; Lamberth L; Hulten KG; Vallejo JG; Mason EO; Kaplan SL
Pediatr Infect Dis J; 2016 Mar; 35(3):263-8. PubMed ID: 26646549
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
17. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
Wong-Beringer A; Joo J; Tse E; Beringer P
Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609
[TBL] [Abstract][Full Text] [Related]
19. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
[TBL] [Abstract][Full Text] [Related]
20. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Hall RG; Blaszczyk AT; Thompson KA; Brouse SD; Giuliano CA; Frei CR; Forcade NA; Mortensen EM; Bell T; Bedimo RJ; Alvarez CA
J Clin Pharm Ther; 2014 Dec; 39(6):653-7. PubMed ID: 25200273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
